Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chloroprocaine HCl
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Spinal Anaesthesia With Chloroprocaine HCl 1% for Elective Lower Limb Procedures of Short Duration.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 25, 2015
Lead Product(s) : Chloroprocaine HCl
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chloroprocaine HCl
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Chloroprocaine 2% vs Ropivacaine 0.75% in Ultrasound-guided Axillary Nerve Block
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 11, 2015
Lead Product(s) : Chloroprocaine HCl
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable